We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufactur... read more Featured Products: More products

Download Mobile App





YHLO Unveils New iBC 900 Automated Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2024

YHLO (Shenzhen, China) is unveiling its latest innovations and breakthroughs in IVD at Medlab Middle East in Dubai, taking place February 5-8, 2024. More...

YHLO is launching the new iBC 900 automated chemistry analyzer which offers multidirectional modular expansion and compatibility with iFlash 3000, making it a game-changer for medical laboratories worldwide. At Medlab Middle East 2024, YHLO is showcasing its iFlash series of chemiluminescence immunoassay analyzers, including the iFlash 1200, iFlash 1800, and iFlash 3000. iFlash 1200 is the latest addition to the iFlash family, offering an unparalleled workstation to low-mid volume testing laboratories, especially with limited floor space. On the other hand, iFlash 1800 offers better efficiency and reliability with fewer outsourced samples, improved in-house controlled quality, and higher throughput. The iFlash 3000 chemiluminescence immunoassay analyzer is designed not only to meet the fundamental needs of large laboratories, but also to improve their efficiency, productivity, and quality.

In addition, YHLO is highlighting the VISION ESR analyzer that redefines the analysis of Erythrocyte Sedimentation Rate (ESR). The ESR is a nonspecific indicator of inflammation in the body. When there is inflammation or infection present, certain proteins in the blood cause red blood cells to stick together and settle more rapidly. By measuring the rate at which red blood cells settle, the VISION ESR analyzer provides valuable information about the inflammatory response, aiding in the diagnosis and monitoring of various conditions. It provides a real ESR curve and Bio-Rad control assigned value and delivers results in 20 minutes with excellent Westergren correlation. It uses primary EDTA tubes and offers batch and STAT test modes with a state-of-the-art design for the least maintenance.

Related Links:
YHLO


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Clinical Chemistry

view channel
Image: The steps involved in the electric field-induced capture and release (EFIRM) assay (Photo courtesy of UCLA School of Dentistry)

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation

Early detection of cancer and other serious diseases is crucial for effective treatment and improved outcomes, yet current diagnostic methods often involve invasive procedures and complex sample preparation.... Read more

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.